• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

Prostate Cancer

Oncology Solutions

The Patient Journey

One in seven men will be diagnosed with prostate cancer,1 with 1.2 million new cases in 2018.2 According to the American Cancer Society the overall 5-year survival rate is 99 percent for all stages of prostate cancer, however when diagnosed at stage IVB, the 5-year survival rate drops significantly to 29 percent.3

Follow up

SIGNA™ PETMR with QuantWorks

Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.
MR_Product Listing Image_2020_320x180_3T_PETMR

LOGIQ™ E10 Ultrasound Series

Next-generation, leadership ultrasound that adapts to your needs, today and into the future.
LOGIQ E10
Scan images of lungs, brain and heart.

The latest in Oncology

References:

1. Prostate Cancer Risk Factors [Internet]. WebMD. 2018 [cited 5 November 2018]. Available from: https://www.webmd.com/prostate-cancer/guide/prostate-cancer-risk-factors 2. Prostate cancer statistics [Internet]. World Cancer Research Fund. 2018 [cited 5 November 2018]. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/prostate-cancer-statistics 3. Survival Rates for Prostate Cancer [Internet]. Cancer.org. 2018 [cited 5 November 2018]. Available from: https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/survival-rates.html#written_by Patel AR, Klein EA.

JB04823XX